The Sensible Choice

MED-EL built BONEBRIDGE on over a decade of experience from recipients around the world. Why trust your patients' hearing to anyone else? We know what it takes to make a dependable bone conduction implant system. See for yourself how MED-EL BONEBRIDGE is the sensible choice.

BONEBRIDGE

BONEBRIDGE

OSIA

OSIA*

  
  
  
  
  
  
  
  
  


Available

 


Not available

 

 

1. BONEBRIDGE was first approved in April 2012 (CE-Mark BCI 601), Osia was first approved in July 2019 (FDA Clearance Osia 1).

2. MED-EL Corporation. (2023). BONEBRIDGE BCI 602 Implant Kit: Instructions for use. MED-EL Elektromedizinische Geräte GmbH.

3. ©Cochlear Limited. (2024). Cochlear™ Osia® OSI300 Implant Physician’s Guide. Cochlear Group.

4. MED-EL Corporation. (2023). BONEBRIDGE SAMBA 2 Audio Processor: Instructions for use. MED-EL Elektromedizinische Geräte GmbH.

5. ©Cochlear Limited. (2023). Datasheet Cochlear™ Osia® System. Cochlear Group.

6. ©Cochlear Limited. (2023). Cochlear™ Osia® Magnetic Resonance Imaging (MRI) Guidelines. Cochlear Group.

*Osia is a trademark of Cochlear Ltd, Australia.

BONEBRIDGE is MR conditional at 1.5 Tesla following the conditions detailed here: medel.com/important-safety-information.

 

Are you ready to get your hands on BONEBRIDGE?

See it in action and experience the SMART DESIGN for yourself.